A recent study by Yagi et al. showed that pitavastatin reduces the incidence of Ang II-induced atrial fibrillation, increases the left atrium, mitigates fibrosis and heart hypertrophy, and negatively regulates Rac1 activity in mice [72]. Here, RAC1 is linked to cardiac hypertrophy.